This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2003 Mar;17(3):637-41.

doi: 10.1038/sj.leu.2402834.

TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23)

R B Lorsbach, J Moore, S Mathew, S C Raimondi, S T Mukatira, J R Downing

PMID: 12646957
DOI: 10.1038/sj.leu.2402834

Case Reports

TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23)

R B Lorsbach et al. Leukemia. 2003 Mar.

. 2003 Mar;17(3):637-41.

doi: 10.1038/sj.leu.2402834.

Authors

R B Lorsbach, J Moore, S Mathew, S C Raimondi, S T Mukatira, J R Downing

PMID: 12646957
DOI: 10.1038/sj.leu.2402834

No abstract available

PubMed Disclaimer

Similar articles

Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis.
Daser A, Rabbitts TH. Daser A, et al. Genes Dev. 2004 May 1;18(9):965-74. doi: 10.1101/gad.1195504. Genes Dev. 2004. PMID: 15132992 Review. No abstract available.
Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations.
Drexler HG, Quentmeier H, MacLeod RA. Drexler HG, et al. Leukemia. 2004 Feb;18(2):227-32. doi: 10.1038/sj.leu.2403236. Leukemia. 2004. PMID: 14671638 Review.
LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23).
Ono R, Taki T, Taketani T, Taniwaki M, Kobayashi H, Hayashi Y. Ono R, et al. Cancer Res. 2002 Jul 15;62(14):4075-80. Cancer Res. 2002. PMID: 12124344
Incidence of MLL rearrangement in acute myeloid leukemia, and a CALM-AF10 fusion in M4 type acute myeloblastic leukemia.
Abdou SM, Jadayel DM, Min T, Swansbury GJ, Dainton MG, Jafer O, Powles RL, Catovsky D. Abdou SM, et al. Leuk Lymphoma. 2002 Jan;43(1):89-95. doi: 10.1080/10428190290000437. Leuk Lymphoma. 2002. PMID: 11911106
Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia.
Thirman MJ, Levitan DA, Kobayashi H, Simon MC, Rowley JD. Thirman MJ, et al. Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):12110-4. doi: 10.1073/pnas.91.25.12110. Proc Natl Acad Sci U S A. 1994. PMID: 7991593 Free PMC article.

See all similar articles

Cited by

Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors.
Tecik M, Adan A. Tecik M, et al. Curr Treat Options Oncol. 2024 Jun;25(6):719-751. doi: 10.1007/s11864-024-01202-7. Epub 2024 May 2. Curr Treat Options Oncol. 2024. PMID: 38696033 Free PMC article. Review.
The role of TET2 in solid tumors and its therapeutic potential: a comprehensive review.
Da W, Song Z, Liu X, Wang Y, Wang S, Ma J. Da W, et al. Clin Transl Oncol. 2024 Apr 10. doi: 10.1007/s12094-024-03478-5. Online ahead of print. Clin Transl Oncol. 2024. PMID: 38598002 Review.
The level of active DNA demethylation compounds in leukocytes and urine samples as potential epigenetic biomarkers in breast cancer patients.
Linowiecka K, Guz J, Dziaman T, Urbanowska-Domańska O, Zarakowska E, Szpila A, Szpotan J, Skalska-Bugała A, Mijewski P, Siomek-Górecka A, Różalski R, Gackowski D, Oliński R, Foksiński M. Linowiecka K, et al. Sci Rep. 2024 Mar 18;14(1):6481. doi: 10.1038/s41598-024-56326-5. Sci Rep. 2024. PMID: 38499584 Free PMC article.
The Killer's Web: Interconnection between Inflammation, Epigenetics and Nutrition in Cancer.
Mecca M, Picerno S, Cortellino S. Mecca M, et al. Int J Mol Sci. 2024 Feb 27;25(5):2750. doi: 10.3390/ijms25052750. Int J Mol Sci. 2024. PMID: 38473997 Free PMC article. Review.
TET Enzymes and 5hmC Levels in Carcinogenesis and Progression of Breast Cancer: Potential Therapeutic Targets.
Salmerón-Bárcenas EG, Zacapala-Gómez AE, Torres-Rojas FI, Antonio-Véjar V, Ávila-López PA, Baños-Hernández CJ, Núñez-Martínez HN, Dircio-Maldonado R, Martínez-Carrillo DN, Ortiz-Ortiz J, Jiménez-Wences H. Salmerón-Bárcenas EG, et al. Int J Mol Sci. 2023 Dec 24;25(1):272. doi: 10.3390/ijms25010272. Int J Mol Sci. 2023. PMID: 38203443 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations
Medical
- Genetic Alliance
Molecular Biology Databases
- GlyGen glycoinformatics resource
Research Materials
- NCI CPTC Antibody Characterization Program

-